AstraZeneca Drug Extends Survival in Late-Stage Stomach Cancer Study
AstraZeneca’s experimental drug sone-ve helped patients with advanced stomach cancer live longer than analysts had expected, according to late-stage trial data presented Sunday.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.